Daniel J. O'Connor
2021 - OncoSec Medical
In 2021, Daniel J. O'Connor earned a total compensation of $3M as Former President and Chief Executive Officer at OncoSec Medical, a 122% increase compared to previous year.
Compensation breakdown
| Bonus | $262,500 |
|---|---|
| Option Awards | $410,872 |
| Salary | $517,731 |
| Other | $1,812,101 |
| Total | $3,003,204 |
O'Connor received $1.8M in other compensation, accounting for 60% of the total pay in 2021.
O'Connor also received $262.5K in bonus, $410.9K in option awards and $517.7K in salary.
Rankings
In 2021, Daniel J. O'Connor's compensation ranked 4,426th out of 12,415 executives tracked by ExecPay. In other words, O'Connor earned more than 64.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,426 out of 12,415 | 64th |
Division Manufacturing | 1,821 out of 5,505 | 67th |
Major group Chemicals And Allied Products | 760 out of 2,375 | 68th |
Industry group Drugs | 677 out of 2,096 | 68th |
Industry Pharmaceutical Preparations | 482 out of 1,546 | 69th |
Source: SEC filing on May 31, 2022.
O'Connor's colleagues
We found two more compensation records of executives who worked with Daniel J. O'Connor at OncoSec Medical in 2021.
News
OncoSec Medical CEO Daniel O'Connor's 2021 pay jumps 122% to $3M
May 31, 2022
OncoSec Medical CEO Daniel O'Connor's 2020 pay rises 15% to $1.4M
March 18, 2021
OncoSec Medical CEO Daniel O'Connor's 2019 pay falls 72% to $1.2M
April 30, 2020
OncoSec Medical CEO Daniel O'Connor's 2018 pay falls 39% to $4.2M
November 8, 2018